Murray Passo to Risk Factors
This is a "connection" page, showing publications Murray Passo has written about Risk Factors.
Connection Strength
0.112
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res (Hoboken). 2019 06; 71(6):717-734.
Score: 0.020
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken). 2019 06; 71(6):703-716.
Score: 0.020
-
The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1999 Jan; 134(1):47-52.
Score: 0.019
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.019
-
Educational and occupational outcomes among young adults with juvenile idiopathic arthritis. Arthritis Rheum. 2008 Oct 15; 59(10):1385-91.
Score: 0.010
-
Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008 Sep; 24(7):620-6.
Score: 0.009
-
Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res. 1998 Oct; 11(5):391-6.
Score: 0.005
-
Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol. 1996 Apr; 23(4):747-52.
Score: 0.004
-
Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr. 1992 Jul; 121(1):56-60.
Score: 0.003
-
Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991 Sep; 18(9):1394-7.
Score: 0.003